Lupin rose 1.11% to Rs 1,577 after the company announced that it has received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility in Somerset at New Jersey.
| Subscribe To Our Free Newsletter |
